Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
BVA issues statement on horse meat
Peter Jones comments on horse meat testing

In the wake of the latest concerns over the presence of phenylbutazone in horses entering the food chain, the BVA has issued a statement regarding the situation. Speaking on the current investigations of the FSA and Defra, president of the BVA Peter Jones said:

"These incidents are understandably causing concern about the integrity of the food chain and so it is vital that the FSA and Defra carry out their investigations as quickly as possible. Consumers must be able to have confidence in the provenance of their food."

Mr Jones added that the association are "pleased to see that testing of beef products has been stepped up and that Defra has announced that all horses slaughtered for human consumption will be sampled for the presence of phenylbutazone (bute).

"A Maximum Residue (MRL) in meat has not been established for the use of phenylbutazone in food-producing animals because of concerns regarding the toxicity of the drug and its metabolites, which can be harmful to human health over a lifetime exposure," he explained.

Mr Jones' words echoed a recent letter issued by the FSA and Defra, which advised veterinary professionals of the importance of strict adherence to the responsibilities set out in the Horse Passport Regulations 2009.

"A horse passport system was introduced because of a shortage of licensed medicines for horses considered safe for human consumption," he said. "Any medicine administered to a horse not having an MRL established, must be entered into the passport by the veterinary surgeon at the time of treatment. This enables the use of such medicines whilst preventing the horse from entering the food chain.

"However, if there is evidence of illegal activity in which unregulated horse meat of unknown provenance is entering the food chain then, of course, there will be an increased risk of phenylbutazone entering the food chain as it is a commonly used drug in horses."

In light of the recent concerns Defra and the FSA have indicated their intention to prosecute those who do not abide by the Horse Passport Regulations. The British Equine Veterinary Association (a division of the BVA), has advised vets to keep blank copies of the form required for emergency cases where the passport is unavailable.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.